Inactive Instrument

All News MiMedx Group Inc Nasdaq

Equities

US6024961012

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cantor Fitzgerald Initiates MiMedx at Overweight Rating With $11 Price Target	Jul. 02	MT
MiMedx Group, Inc.(NasdaqCM:MDXG) added to Russell 3000 Growth Index	Jun. 30	CI
MiMedx Group, Inc.(NasdaqCM:MDXG) added to Russell Microcap Growth Index	Jun. 30	CI
MiMedx Group, Inc.(NasdaqCM:MDXG) added to Russell 3000E Growth Index	Jun. 30	CI
MiMedx Group, Inc.(NasdaqCM:MDXG) added to Russell 2000 Growth Index	Jun. 30	CI
MiMedx Group, Inc.(NasdaqCM:MDXG) added to Russell 2500 Growth Index	Jun. 30	CI
MiMedx Group, Inc.(NasdaqCM:MDXG) added to Russell Small Cap Comp Growth Index	Jun. 30	CI
MiMedx Group Promotes Kim Moller to Chief Commercial Officer	Jun. 26	MT
MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer	Jun. 26	AQ
MiMedx Group, Inc. Announces the Appointment of Kim Moller to Chief Commercial Officer	Jun. 26	CI
4 Stocks to Watch in the Booming Regenerative Medicine Market	May. 20	AQ
MIMEDX to Participate in Upcoming Investor Conferences	May. 15	AQ
Transcript : MiMedx Group, Inc., Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 Revenue $84.7M, vs. Street Est of $79.4M	Apr. 30	MT
Earnings Flash (MDXG) MIMEDX GROUP Posts Q1 EPS $0.07, vs. Street Est of $0.04	Apr. 30	MT
MiMedx: Q1 Earnings Snapshot	Apr. 30	AQ
MiMedx Group, Inc. Reports Consolidated Impairment for the First Quarter Ended March 31, 2024	Apr. 30	CI
MiMedx Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
MIMEDX Announces First Quarter 2024 Operating and Financial Results	Apr. 30	AQ
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30	Apr. 16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News MiMedx Group Inc Nasdaq

Equities

US6024961012

All News

Filters